Siemens Healthineers-backed USARAD begins online CT scan consulting effort.
USARAD, a global teleradiology company backed by Siemens Healthineers, announced this week it will launch a first-of-its-kind screening program to identify patients with COVID-19.
This program, which will operate through USARAD’s SecondOpinions.com division, will connect radiologists to other providers. According to a company statement, chest CT-trained radiologists will provide screening diagnostics and consultations together with other medical specialists, including pulmonologists and infectious disease experts.
Launched in partnership with Medical Diagnostic Web (MDW), a blockchain-powered marketplace that provides access to hundreds of radiologists ready to provide diagnostic assistance, this new program allows providers to upload images through USARAD’s online service 24-hours-a-day. Radiologists will be on-hand to help either diagnose or rule out COVID-19, and as the volume of imaging studies increases, AI algorithms will be available to assist in decision-making.
Alongside its partnership with MDW, USARAD also announced a collaboration with the Israel-based Nanox Imaging to facilitate bringing Nanox’s mobile imaging system to high-risk areas, supporting preventive COVID-19 screening efforts in these locations.
“USARAD, together with its strategic partners, MDW and Nanox, is available to help patients world-wide during the current COVID-19 pandemic by leveraging the latest science and technology,” said Michael Yuz, M.D., USARAD founder and chief executive officer. “We are doing everything possible to reduce panic, bringing the peace of mind to millions of patients world-wide.”
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).